← back to search

Holger Hof

University Hospital Heidelberg · DE
Area of research
Radiation · Cancer Research
Research interest
Research interests include Medicine, Breast cancer, Radiation therapy, Randomized controlled trial, Internal medicine, and Oncology.
h-index
citations
364
works
9
NIH funding
primary concept
email

Recent publications

Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial
International Journal of Radiation Oncology*Biology*Physics 2023cited by 9position: middledoi
Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients’ and Physicians’ Assessment from the Randomized IMRT-MC2 Trial
Cancers 2022cited by 4position: middledoi
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial
Radiotherapy and Oncology 2021cited by 17position: middledoi
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)
International Journal of Radiation Oncology*Biology*Physics 2020cited by 59position: middledoi
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
Radiation Oncology 2020cited by 17position: middledoi
Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial
International Journal of Radiation Oncology*Biology*Physics 2015cited by 89position: middledoi
Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy
BMC Cancer 2015cited by 56position: middledoi
Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study
BMC Cancer 2013cited by 60position: middledoi
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit
The Breast 2012cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health8 papers (2012–2023)Semi Harrabi · Heidelberg University5 papers (2020–2023)David Krug · University Hospital Heidelberg5 papers (2020–2023)Nathalie Arians · Heidelberg University5 papers (2020–2023)Juliane Hörner‐Rieber · German Cancer Research Center5 papers (2020–2023)Tobias Förster · Ludwig-Maximilians-Universität München5 papers (2020–2023)Ingmar Schlampp · University Hospital Heidelberg5 papers (2020–2023)N. Weidner · European Organisation for Research and Treatment of Cancer4 papers (2020–2023)Laila König · Heidelberg University4 papers (2020–2023)Matthias Häfner · University Hospital Heidelberg4 papers (2020–2023)Vanessa Heinrich · University of Tübingen4 papers (2020–2023)Michael Golatta · University Medical Center Hamburg-Eppendorf4 papers (2012–2023)Christof Sohn · University Hospital Heidelberg4 papers (2012–2021)Jörg Heil · Breast Center3 papers (2021–2023)Cornelia M. Ulrich · University of Utah3 papers (2013–2015)Joachim Wiskemann · Heidelberg University3 papers (2013–2015)Eva Meixner · DKFZ-ZMBH Alliance3 papers (2021–2023)Oliver Klassen · German Sport University Cologne3 papers (2013–2015)Karin Potthoff · Iomedico (Germany)3 papers (2013–2015)Johannes Hüsing · Heidelberg University3 papers (2020–2023)